{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:07:25Z","timestamp":1767992845258,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.jemermed.2012.12.022","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T04:32:49Z","timestamp":1366345969000},"page":"1201-1210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Clinical Use of Prothrombin Complex Concentrate"],"prefix":"10.1016","volume":"44","author":[{"given":"Jason","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marci","family":"DeLosSantos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2012.12.022_bib1","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1161\/STROKEAHA.111.615260","article-title":"Effect of increased warfarin use on warfarin-related cerebral hemorrhage: a longitudinal population-based study","volume":"42","author":"Huhtakangas","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jemermed.2012.12.022_bib2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1345\/aph.1P605","article-title":"Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin","volume":"45","author":"Chapman","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jemermed.2012.12.022_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1055\/s-0038-1655992","article-title":"Emergency oral anticoagulation reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy","volume":"77","author":"Makris","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jemermed.2012.12.022_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1345\/aph.1Q588","article-title":"Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal","volume":"46","author":"Baggs","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jemermed.2012.12.022_bib5","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jemermed.2012.12.022_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12028-009-9310-0","article-title":"Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature","volume":"12","author":"Bershad","year":"2010","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jemermed.2012.12.022_bib7","series-title":"Practice guidelines for blood transfusion: a compilation From recent peer-reviewed literature","author":"Miller","year":"2007"},{"key":"10.1016\/j.jemermed.2012.12.022_bib8","series-title":"Recombinant activated factor seven (NovoSeven\u00ae)","year":"1999"},{"key":"10.1016\/j.jemermed.2012.12.022_bib9","first-page":"489","article-title":"Results of the CONTROL trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage","volume":"69","author":"Hauser","year":"2010","journal-title":"J Trauma"},{"key":"10.1016\/j.jemermed.2012.12.022_bib10","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2012.12.022_bib11","unstructured":"Bebulin VH (Factor IX Complex) vapor heated [package insert]. Westlake Village, CA: Baxter Healthcare Corporation; September\u00a02006."},{"key":"10.1016\/j.jemermed.2012.12.022_bib12","unstructured":"Profilnine SD (Factor IX Complex) [package insert]. Los Angeles, CA: Grifols Biologicals Inc.; March\u00a02010."},{"key":"10.1016\/j.jemermed.2012.12.022_bib13","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1345\/aph.1Q096","article-title":"Prothrombin complex concentrate for critical bleeding","volume":"45","author":"Patanwala","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jemermed.2012.12.022_bib14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1345\/aph.1Q288","article-title":"Using prothrombin complex concentrate to rapidly reverse oral anticoagulation effects","volume":"45","author":"Dager","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jemermed.2012.12.022_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.wneu.2010.06.030","article-title":"Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII","volume":"74","author":"Pinner","year":"2010","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jemermed.2012.12.022_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1055\/s-0030-1265286","article-title":"Clinical utility of thromboelastography: one size does not fit all","volume":"36","author":"Wegner","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jemermed.2012.12.022_bib17","first-page":"148","article-title":"Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage","volume":"9","author":"Imberti","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jemermed.2012.12.022_bib18","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1537-2995.2008.02080.x","article-title":"Suboptimal effect of three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic INR due to warfarin overdose","volume":"49","author":"Holland","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.jemermed.2012.12.022_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0268-960X(98)90028-5","article-title":"Management of oral anticoagulation-induced intracranial haemorrhage","volume":"12","author":"Butler","year":"1998","journal-title":"Blood Rev"},{"key":"10.1016\/j.jemermed.2012.12.022_bib20","first-page":"117","article-title":"Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal?","volume":"9","author":"Markis","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jemermed.2012.12.022_bib21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1538-7836.2006.01815.x","article-title":"Urgent reversal of warfarin with prothrombin complex concentrate","volume":"4","author":"Lankiewicz","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jemermed.2012.12.022_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3171\/2011.11.JNS11836","article-title":"Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage","volume":"116","author":"Sarode","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jemermed.2012.12.022_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.thromres.2004.09.002","article-title":"Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation","volume":"115","author":"Yasaka","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.jemermed.2012.12.022_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.thromres.2005.08.005","article-title":"Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulation therapy: an open, prospective randomized controlled trial","volume":"118","author":"Van Aart","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.jemermed.2012.12.022_bib25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5694\/j.1326-5377.2004.tb06407.x","article-title":"Warfarin reversal: consensus guidelines, on behalf of the Australasian society of thrombosis and hemostasis","volume":"181","author":"Baker","year":"2004","journal-title":"Med J Aust"},{"key":"10.1016\/j.jemermed.2012.12.022_bib26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00006123-199911000-00020","article-title":"Use of factor IX complex in warfarin-related intracranial hemorrhage","volume":"45","author":"Boulis","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jemermed.2012.12.022_bib27","unstructured":"A randomized, open-label, efficacy and safety study of OCTAPLEX and fresh frozen plasma (FFP) in patients under vitamin K antagonist therapy with the need for urgent surgery or invasive procedures [NCT00618098]. Available at: www.clinicaltrials.gov. Accessed October 7,\u00a02011."},{"key":"10.1016\/j.jemermed.2012.12.022_bib28","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/01.STR.0000221786.81354.d6","article-title":"Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, FFP and PCC","volume":"37","author":"Huttner","year":"2006","journal-title":"Stroke"},{"issue":"S2","key":"10.1016\/j.jemermed.2012.12.022_bib29","article-title":"Cost-effectiveness of prothrombin complex concentrate compared to fresh frozen plasma in emergency warfarin reversal in the UK","volume":"9","author":"Guest","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jemermed.2012.12.022_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MBC.0b013e3282f185c9","article-title":"Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII","volume":"19","author":"Taketomi","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jemermed.2012.12.022_bib31","first-page":"76","article-title":"Ximelgatran (Exanta): alternative to warfarin?","volume":"18","author":"Vaughan","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.jemermed.2012.12.022_bib32","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2012.12.022_bib33","unstructured":"Rivaroxaban (Xarelto\u00ae) [Package Insert]. Titusville, NJ: Janssen Pharmaceuticals; December\u00a02011."},{"key":"10.1016\/j.jemermed.2012.12.022_bib34","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.111.029017","article-title":"Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects","volume":"124","author":"Eerenberg","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jemermed.2012.12.022_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1160\/TH11-09-0668","article-title":"Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents","volume":"107","author":"Fukuda","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jemermed.2012.12.022_bib36","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1160\/TH09-11-0758","article-title":"Dabigatran etexilate \u2013 a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity","volume":"103","author":"Van Ryn","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jemermed.2012.12.022_bib37","first-page":"1151","article-title":"Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model","volume":"68","author":"Dickneite","year":"2010","journal-title":"J Trauma"},{"key":"10.1016\/j.jemermed.2012.12.022_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/bja\/aen391","article-title":"Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model","volume":"102","author":"Dickneite","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jemermed.2012.12.022_bib39","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/cc10078","article-title":"Transfusion in trauma: thromboelastography guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma based therapy","volume":"15","author":"Schochl","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jemermed.2012.12.022_bib40","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/j.1538-7836.2010.04062.x","article-title":"Treatment of massive bleeding with prothrombin complex concentrate: argument against","volume":"8","author":"Godier","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jemermed.2012.12.022_bib41","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1111\/j.1538-7836.2010.04052.x","article-title":"Treatment of massive bleeding with prothrombin complex concentrate: argument for","volume":"8","author":"Tanaka","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jemermed.2012.12.022_bib42","first-page":"828","article-title":"Factor IX complex for the\u00a0correction of traumatic coagulopathy","volume":"72","author":"Joseph","year":"2012","journal-title":"J Trauma"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467912017283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467912017283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:27:26Z","timestamp":1760027246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467912017283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0736467912017283"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2012.12.022","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Use of Prothrombin Complex Concentrate","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2012.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}